Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 175 Precursor Cell Lymphoblastic Leukemia-Lymphoma 161 Lymphoma, Large B-Cell, Diffuse 149 Leukemia 89 Burkitt Lymphoma 77 Lymphoma, Non-Hodgkin 76 Lymphoma, Follicular 69 Lymphoma, Mantle-Cell 44 Hodgkin Disease 40 Central Nervous System Neoplasms 35 Neuroblastoma 34 Sarcoma 30 Lymphoma, Large-Cell, Immunoblastic 25 Lymphoma, B-Cell 25 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, Large-Cell, Anaplastic 22 Recurrence 20 Neoplasms 20 Rhabdomyosarcoma 19 Multiple Myeloma 19 Lymphoma, B-Cell, Marginal Zone 19 Leukemia, Lymphocytic, Chronic, B-Cell 19 Lymphoma, T-Cell, Peripheral 18 Medulloblastoma 17 Brain Neoplasms 17 Leukemia, Biphenotypic, Acute 16 HIV Infections 16 Dendritic Cell Sarcoma, Interdigitating 16 Sarcoma, Ewing 14 Retinoblastoma 13

Interventions

Temozolomide 2 vorasidenib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 pamiparib 1 lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 cixutumumab 1 Vorinostat 1 Vincristine 1 Valproic Acid 1 Thiotepa 1 Sunitinib 1 Radiotherapy 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Oncolytic Virotherapy 1 ONC206 1 Melphalan 1 Maintenance Chemotherapy 1 Lutetium-177 1 Lutetium 1 Lomustine 1 Interleukin-12 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Erlotinib Hydrochloride 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡